ecancermedicalscience editor's choice for July and August 2014

Treatment options in adult chronic idiopathic thrombocytopenic purpura: Panel discussion

Melanoma live: Making patient-focused therapy decisions

Repurposing generics to fight cancer and the work of the ReDO Project

Continual low-dose metronomic chemotherapy as potentially preferable to aggressive strategies

Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies

New metronomic approach to neuroblastoma

Advances in multiple myeloma: Expert panel discussion

Industry view of targeted therapy combinations in oncology

Genomic complexity of metastatic disease and the conundrum of combinations

Complexity of intra- and inter-pathway loops in colon cancer and melanoma: Implications for targeted therapies

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care